International Organising Committee

Chairman

Prof. Marko ANDERLUH (University of Ljubljana, Ljubljana, Slovenia)

Members

	Dr Yves P. AUBERSON (Novartis Institutes for Biomedical Research, Basel, Switzerland)
	Prof. Roberto DI SANTO (Sapienza University of Rome, Rome, Italy)
	Dr Phil JONES (BioAscent, Glasgow, United Kingdom)
	Dr Jürgen MACK (Boehringer Ingelheim, Biberach an der Riss, Germany)
	Prof. Hans Ulrich STILZ (Novo Nordisk, Cambridge, United States)
	Dr Cornelia ZUMBRUNN (Idorsia Pharmaceuticals, Allschwil, Switzerland)

Local Organising Committee

Members

	Prof. Gregor ANDERLUH (National Institute of Chemistry, Ljubljana, Slovenia)
	Prof. Marko ANDERLUH (University of Ljubljana, Ljubljana, Slovenia)
	Prof. Janez ILAS (University of Ljubljana, Ljubljana, Slovenia)
	Dr Ziga JAKOPIN (University of Ljubljana, Ljubljana, Slovenia)
	Dr Simona JEVSEVAR (Lek d.d., Ljubljana, Slovenia)
	Prof. Danijel KIKELJ (University of Ljubljana, Ljubljana, Slovenia)
	Dr Gregor KOSEC (Acies Bio, Ljubljana, Slovenia)
	Dr Gašper MARC (F. Hoffmann-La Roche, Ljubljana, Slovenia)
	Assoc. Prof. Lucija PETERLIN MASIC (University of Ljubljana, Ljubljana, Slovenia)
	Prof. Jurij SVETE (University of Ljubljana, Ljubljana, Slovenia)

International Scientific Committee

Members

	Prof. Sergey Olegovich BACHURIN (Institute of Physiologically Active Compounds, Chernogolovka, Russia)
	Prof. Eliezer BARREIRO (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil)
	Dr Jonathan BENNETT (Merck, Sharp & Dohme, Boston, United States)
	Dr Hayley BINCH (F. Hoffmann-La Roche, Basel, Switzerland)
	Dr Mark BUNNAGE (Vertex Pharmaceuticals, Boston, United States)
	Dr Nicholas CARRUTHERS (Johnson & Johnson R&D, San Diego, United States)
	Prof. Kelly CHIBALE (University of Cape Town, Cape Town, South Africa)
	Dr Ian CHURCHER (BenevolentAI, Cambridge, United Kingdom)
	Prof. Gabriele COSTANTINO (University of Parma, Parma, Italy)
	Prof. Flavio DA SILVA EMERY (University of Sao Paulo, Ribeirao Preto, Brazil)
	Prof. Benoit DEPREZ (Institut Pasteur of Lille, Lille, France)
	Dr Daniele DONATI (Nerviano Medical Sciences, Nerviano, Italy)
	Prof. Marcin DRAG (Wroclav University of Technology, Wroclaw, Poland)
	Prof. Antony GEE (King's College London, London, United Kingdom)
	Prof. Stanislav GOBEC (University of Ljubljana, Ljubljana, Slovenia)
	Prof. Maria Pilar GOYA LAZA (Instituto de Quimica Medic, CSIC, Madrid, Spain)
	Dr Renate GRIFFITH (University of New South Wales, UNSW Sydney, Australia)
	Dr Adrian HALL (UCB Pharma S.A., Braine-l'Alleud, Belgium)
	Dr Gregory HOLLINGWORTH (Novartis Pharma AG, Basel, Switzerland)
	Dr Bayard HUCK (Merck Biopharma, Darmstadt, Germany)
	Prof. Ad P. IJZERMAN (Leiden University, Leiden, The Netherlands)
	Dr Rolf JAUTELAT (Bayer, Wuppertal, Germany)
	Dr Allan JORDAN (Cancer Research UK Manchester Institute, Manchester, United Kingdom)
	Prof. Ivars KALVINS (Latvian Institute of Organic Synthesis, Riga, Latvia)
	Prof. György KESERU (Hungarian Academy of Sciences, Budapest, Hungary)
	Prof. Stefan LAUFER (University of Tübingen, Tübingen, Germany)
	Dr Malin LEMURELL (AstraZeneca, Gothenburg, Sweden)
	Dr John E. MACOR (Sanofi, Natick, United States)
	Prof. Matilde MARQUES (Instituto Superior Técnico, ULisboa, Lisboa, Portugal)
	Dr Lieven MEERPOEL (Janssen R&D, Belgium)
	Dr Fabrizio MICHELI (Aptuit, Verona, Italy)
	Dr Christian MONTALBETTI (Inventiva, Daix, France)
	Prof. Dario NERI (ETH Zürich, Zürich, Switzerland)
	Prof. Ulf NILSSON (Lund University/Galecto Biotech, Lund, Sweden)
	Dr Daniel OBRECHT (Polyphor, Allschwil, Switzerland)
	Dr Thorsten OOST (Boehringer Ingelheim, Biberach, Germany)
	Dr Leena OTSOMAA (Orion Pharma, Espoo, Finland)
	Prof. Roberto PELLICCIARI (TES Pharma srl, Corciano, Italy)
	Dr Ivo PIANTANIDA (Rudjer Boskovic Institute, Zagreb, Croatia)
	Dr Paul RATCLIFFE (Grünenthal, Germany)
	Dr David REES (Astex Pharmaceuticals, Cambridge, United Kingdom)
	Dr Didier ROCHE (Edelris, Lyon, France)
	Prof. Leonardo SCAPOZZA (University of Geneva, Genève, Switzerland)
	Prof. Bogdan SOLAJA (University of Belgrade, Belgrade, Serbia)
	Prof. Jan STEYAERT (VUB, Brussels, Belgium)
	Prof. Vincenzo SUMMA (IRBM - MRL, Naples, Italy)
	Prof. Giulio SUPERTI-FURGA (Research Center for Molecular Medicine (CEMM), Vienna, Austria)
	Prof. Edward TATE (Imperial College London, London, United Kingdom)
	Dr Atli THORARENSEN (Pfizer, New-York, United States)
	Prof. Henk TIMMERMAN (VU University Amsterdam, Oegstgeest, The Netherlands)
	Prof. Nicholas John TURNER (University of Manchester, Manchester, United Kingdom)
	Dr Klaus URBAHNS (Merck KGaA, Billerican, MA, United States)
	Dr Luc VAN HIJFTE (MercachemSyncom, Nijmegen, The Netherlands)
	Dr Franz VON NUSSBAUM (BAYER AG, Berlin, Germany)
	Prof. Herbert WALDMANN (Max Planck Institute of Molecular Physiology, Dortmund, Germany)
	Dr Ming-Qiang ZHANG (Amgen, Shanghai City, China)
	Prof. Grigorios ZOIDIS (EKPA - ELKE, Athens, Greece)